文献速递心外重症与机械循环支持

高危右心衰竭患者双心室辅助装置作为心脏移植过渡的应用评估

Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
PubMed 文献 · J Thorac Cardiovasc Surg · 2016-11-15

该研究评估了预先计划的双心室辅助装置(BiVAD)在高危术后右心衰竭患者中作为心脏移植过渡的策略。2010至2014年间,20例接受BiVAD,21例接受左心室辅助装置(LVAD),比较术前特征与术后结局。结果显示BiVAD组更年轻、女性更多、非缺血性心肌病更多,术前INTERMACS分级更差、心脏指数更低、右心功能更差,但两组装置生存率及1年总生存率无显著差异,BiVAD组等待移植时间更短。

要点

  • 对于高危术后右心衰竭患者,预先计划的BiVAD作为移植过渡可行。
  • BiVAD组患者病情更重,但生存结局与LVAD组相似。
  • BiVAD组心脏移植等待时间更短(中位154天 vs 302天,P<.001)。

核心结论

  • 预先计划的BiVAD对于高危术后右心衰竭患者是心脏移植过渡的可行选择。
  • 尽管BiVAD组病情更重,其结局与 contemporary LVAD 接受者相似。

研究设计与样本

  • 2010至2014年间,根据术后右心衰竭估计风险,将20例分入预先计划BiVAD组,21例分入LVAD组。
  • 比较两组术前特征和术后结局。

主要发现

  • BiVAD组更年轻、女性更多、非缺血性心脏病更多。
  • BiVAD组术前INTERMACS分级更差、心脏指数更低、右心功能更差。
  • 装置生存至移植/撤除/终点:BiVAD 90% vs LVAD 86%(无显著差异)。
  • 心脏移植等待时间中位数:BiVAD 154天 vs LVAD 302天(P<.001)。
  • 1年总生存率:BiVAD 85%(95%CI 62-95) vs LVAD 86%(95%CI 64-95)(无显著差异)。

临床怎么用

  • 对于估计高危术后右心衰竭患者,可考虑预先计划BiVAD作为移植过渡。
  • BiVAD组尽管病情更重,结局与LVAD组相似,且等待移植时间更短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Right ventricular failure in patients treated using left ventricular assist devices is associated with poor outcomes. We assessed the strategy of preplanned biventricular assist device implantation in patients with a high risk for right ventricular failure. METHODS: Between 2010 and 2014, we assigned 20 patients to preplanned biventricular assist device and 21 patients to left ventricular assist device as a bridge to heart transplantation on the basis of the estimated risk of postimplant right ventricular failure. Preimplant characteristics and postimplant outcomes were compared between the 2 groups. RESULTS: Patients with a biventricular assist device were younger, more often female, and more frequently had nonischemic heart disease than left ventricular assist device recipients. At preoperative assessment, biventricular assist device recipients had poorer Interagency Registry for Mechanically Assisted Circulatory Support profiles, a lower cardiac index, and more compromised right ventricular function. Survival on device to heart transplantation/weaning/destination for biventricular assist device and left ventricular assist device recipients was 90% versus 86% (not significant), with shorter heart transplantation waiting times for biventricular assist device recipients (median days, 154 vs 302, P < .001). Overall survival at 1 year was 85% (95% confidence interval, 62-95) versus 86% (95% confidence interval, 64-95) (not significant). The majority of both biventricular assist device and left ventricular assist device recipients could be discharged to home during the heart transplantation waiting time (55% vs 71%, not significant), and complication rates on device were comparable between groups (major stroke 10% vs 10%, not significant). CONCLUSIONS: Planned in advance, the biventricular assist device seems to be a feasible option as bridge to heart transplantation for patients with a high risk of postimplant right ventricular failure. The outcomes for these patients were similar to those observed for contemporary left ventricular assist device recipients, despite those receiving biventricular assist devices being more severely ill.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bartfay SE, Dellgren G, Lidén H, et al. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure? J Thorac Cardiovasc Surg. 2016. PMID: 27955912. doi:10.1016/j.jtcvs.2016.09.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。